Where innovation meets reliability in translational science

Airmeith Bioscience provide bespoke design and focused strategies for your therapeutic targets, drug discovery and preclinical investigation.

ABout us

Precision Engineered in vivo Models for Transformative Research

At Airmeith Bioscience, we make complex in vivo research simpler and faster. Our fully integrated platform takes your project from concept to high-quality data, supporting every stage of the study. We’re built for precision, efficiency, and real translational impact, helping you bring your assets closer to the clinic. 

TESTIMONIALS

End-to-end project implementation

End-to-end project implementation

End-to-end project implementation

End-to-end project implementation

PREVIOUS COLLABORATORS

OUR WORK

Scientific expertise and operational excellence

Our work has driven discovery – Our team develops advanced murine and cell line platforms and conducts in vivo studies across neurological, autoimmune, and oncology indications. These models enable target validation, mechanism-of-action studies, and preclinical efficacy testing, accelerating the path from discovery to clinical development. Explore some of our work here. 

OUR SERVICES

Redefining how complex in vivo research is conducted

Our range of capabilities and services provide comprehensive research support. We specialise in the generation of genetically engineered and humanised disease models to support translational research. We offer services in in vitro investigation and preclinical in vivo disease models, along with full end-to-end project management, designed to de-risk and accelerate your research deliver the robust data you need. 

In vitro

Transgenic
Technologies

Novel model generation

Preclinical

Contact our team of scientific experts to discuss your project

We do this by offering a fully integrated, end-to-end platform for genetically altered model development. From concept to data, we provide a seamless solution that supports the entire lifecycle of your study—designed for precision, efficiency, and translational.

RESOURCES

Latest industry news, research, insights and learnings

Lorem ipsum dolor sit amet consectetur. Scelerisque in est egestas at turpis duis vulputate. Ut tempor ac nunc auctor viverra interdum nunc vestibulum enim. Ultrices nibh intege.

Lorem ipsum dolor sit amet consec tetur. Euis mod lectus vitae elementum velit aliquet.

Lorem ipsum dolor sit amet consec tetur. Euis mod lectus vitae elementum velit aliquet.